Glycosylation potential of human prostate cancer cell lines
- 28 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Glycoconjugate Journal
- Vol. 29 (7), 525-537
- https://doi.org/10.1007/s10719-012-9428-8
Abstract
Altered glycosylation is a universal feature of cancer cells and altered glycans can help cancer cells escape immune surveillance, facilitate tumor invasion, and increase malignancy. The goal of this study was to identify specific glycoenzymes, which could distinguish prostate cancer cells from normal prostatic cells. We investigated enzymatic activities and gene expression levels of key glycosyl- and sulfotransferases responsible for the assembly of O- and N-glycans in several prostatic cells. These cells included immortalized RWPE-1 cells derived from normal prostatic tissues, and prostate cancer cells derived from metastasis in bone (PC-3), brain (DU145), lymph node (LNCaP), and vertebra (VCaP). We found that all cells were capable of synthesizing complex N-glycans and O-glycans with the core 1 structure, and each cell line had characteristic biosynthetic pathways to modify these structures. The in vitro measured activities corresponded well to the mRNA levels of glycosyltransferases and sulfotransferases. Lectin and antibody binding to whole cells supported these results, which form the basis for the development of tumor cell-specific targeting strategies.Keywords
This publication has 63 references indexed in Scilit:
- Core 2 N‐acetylglucosaminyltransferase‐1 expression induces aggressive potential of testicular germ cell tumorInternational Journal of Cancer, 2010
- Over-expression of ST3Gal-I promotes mammary tumorigenesisGlycobiology, 2010
- Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell traffickingProceedings of the National Academy of Sciences of the United States of America, 2009
- Core3 O-Glycan Synthase Suppresses Tumor Formation and Metastasis of Prostate Carcinoma PC3 and LNCaP Cells through Down-regulation of α2β1 Integrin ComplexOnline Journal of Public Health Informatics, 2009
- The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglusaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomasBMC Cancer, 2009
- Glycoproteomics for Prostate Cancer Detection: Changes in Serum PSA Glycosylation PatternsJournal of Proteome Research, 2008
- Elevated expression of L-selectin ligand in lymph node-derived human prostate cancer cells correlates with increased tumorigenicityGlycoconjugate Journal, 2008
- Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectinGlycobiology, 2008
- Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycansThe Journal of Experimental Medicine, 2007
- Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functionsEMBO Reports, 2006